+ view all (2023) Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
By week 48 (approximately one year), participants lost more than 24% of their starting weightan average of about 58 pounds.[4] This level of weight loss appears greater than what has been observed in studies of medications like Wegovy or Ozempic.[6,7] Additionally, nearly all 338 participants who took lower doses of retatrutide experienced weight reductions between 5% and 15%.[4] Even modest weight loss can have meaningful health benefits
Turn the vial upright and then remove the needle
Your current health status, including any existing medical conditions and previous weight loss attempts, is crucial in determining potential benefits
Safety Considerations and Contraindications GHK-Cu has an excellent safety profile in clinical use, but there are important considerations
Our team can work with you to set up a payment schedule that aligns with your budget, making treatment more affordable and manageable